TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30259127

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation (Lactobacillus casei, Bifidobacterium lactis, Lactobacillus rhamnosus, Lactobacillus plantarum, fructooligosaccharide, galactooligosaccharide, and biotin) for 8 weeks
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation
Number of subjects: 320
Study: 26913388

Group type: EXPERIMENTAL
Intervention: Rituximab combined with fludarabine and cyclophosphamide
Number of subjects: 40

Group type: COMPARATOR
Intervention: CHOP chemotherapy
Number of subjects: 40
Study: 25411294

Group type: EXPERIMENTAL
Intervention: Non-enteric-coated (non-EC) granules (500 mg)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Non-enteric-coated (non-EC) granules (1000 mg)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Non-enteric-coated (non-EC) granules (1500 mg)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Enteric-coated (EC) granules (500 mg)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Enteric-coated (EC) granules (1000 mg)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Enteric-coated (EC) granules (1500 mg)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Cumulative 48-h FCA of EC calcium
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: FCA for 1000 mg dose compared to 500 mg
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: FCA for 1500 mg dose compared to 500 mg
Number of subjects: 49
Study: 22420492

Group type: EXPERIMENTAL
Intervention: DHEAS 50 mg daily
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 20978193

Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D (25(OH)D) levels <25 nmol/L
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D (25(OH)D) levels 25 to <37.5 nmol/L
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D (25(OH)D) levels 37.5 to <50 nmol/L
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Season-specific quartiles Q1 versus Q4
Number of subjects: 250
Study: 18603279

Group type: EXPERIMENTAL
Intervention: Coextensive gratings with higher contrast
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coextensive gratings with lower contrast
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gratings moving in opposite directions with a vertical gap of 1 degree or more
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gratings moving in the same direction with a vertical gap of 8 degrees
Number of subjects: 0
Study: 16037731

Group type: EXPERIMENTAL
Intervention: Gabapentin 800 mg (in two equally divided doses)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 12577433

Group type: EXPERIMENTAL
Intervention: Integrative traditional Chinese and western medicine (TCM‐WM)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Chinese herbal medicine alone (TCM)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Western medicine alone (WM)
Number of subjects: 120
Study: 9701192

Group type: EXPERIMENTAL
Intervention: Maximal graded exercise test
Number of subjects: 14

Group type: COMPARATOR
Intervention: 30‐min rest period
Number of subjects: 14
Study: 8024076

Group type: EXPERIMENTAL
Intervention: Micronized halofantrine (8 mg/kg every 6 hr in three doses)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Chloroquine (25 mg/kg for a 48-hr period) plus clindamycin (5 mg/kg every 12 hr in six doses)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Chloroquine (25 mg/kg for a 48-hr period) plus doxycycline (2 mg/kg every 12 hr in six doses)
Number of subjects: 102
Study: 2557685

Group type: EXPERIMENTAL
Intervention: Calcium phosphate remineralizing slurry (CPRS) for 10 minutes
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Calcium phosphate remineralizing slurry (CPRS) for 1 hour
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Viscous CPRS containing carboxymethyl cellulose (CMC) gel for 8 hours
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group soaked in saliva-like (SL) solution
Number of subjects: 3
Study: 1101719

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control
Number of subjects: 100
Study: 31055663

Group type: EXPERIMENTAL
Intervention: Lumbar limited discectomy
Number of subjects: 278
Study: 28328709

Group type: EXPERIMENTAL
Intervention: Low-fluence Q-switched 1,064-nm neodymium:yttrium-aluminum-garnet laser (QSNYL) weekly for 10 sessions on one cheek
Number of subjects: 22
Study: 25922285

Group type: COMPARATOR
Intervention: Standard setting with three proximal humeral head screws alone (Group I)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Supplemental unlocked calcar screw (CS) (Group II)
Number of subjects: 14
Study: 23934747

Group type: EXPERIMENTAL
Intervention: AIMS (Anesthesia Information Management System)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Handwritten records
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Intensive observation
Number of subjects: 400

Group type: COMPARATOR
Intervention: Reduced observation
Number of subjects: 400
Study: 21384650

Group type: EXPERIMENTAL
Intervention: 1.25 mg droperidol intravenously before operation
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no droperidol)
Number of subjects: 200
Study: 19590447

Group type: EXPERIMENTAL
Intervention: Weight loss intervention
Number of subjects: 170
Study: 17257447

Group type: EXPERIMENTAL
Intervention: Epoetin alfa
Number of subjects: 16378
Study: 15538041

Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM) 20 mg
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Toremifene (TOR) 40 mg
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Switch from TAM to TOR
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Switch from TOR to TAM
Number of subjects: 197
Study: 11053173

Group type: EXPERIMENTAL
Intervention: Midwife led debriefing
Number of subjects: 1041

Group type: COMPARATOR
Intervention: Usual postpartum care
Number of subjects: 1041
Study: 8971283

Group type: EXPERIMENTAL
Intervention: 10 mg cisapride
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 20 mg cisapride
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 1617510

Group type: EXPERIMENTAL
Intervention: Fish oil (15 g/day MaxEPA, 4.5 g eicosapentaenoic and docosahexaenoic acids)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Olive oil (control)
Number of subjects: 125
Study: 6367719

Group type: EXPERIMENTAL
Intervention: Fluosol-DA 20% (PFC emulsion)
Number of subjects: 13
Study: 29390862

Group type: EXPERIMENTAL
Intervention: Process incentives (earned by attending primary care visits and/or receiving prescription medication refills)
Number of subjects: 1879

Group type: EXPERIMENTAL
Intervention: Outcome incentives (earned by reducing systolic blood pressure or hemoglobin A1c levels)
Number of subjects: 1879

Group type: EXPERIMENTAL
Intervention: Combined process and outcome incentives
Number of subjects: 1879

Group type: COMPARATOR
Intervention: Control (no incentives)
Number of subjects: 1879
Study: 27149587

Group type: EXPERIMENTAL
Intervention: Swing resistance training
Number of subjects: 14

Group type: COMPARATOR
Intervention: Swing assistance training
Number of subjects: 14
Study: 25778507

Group type: EXPERIMENTAL
Intervention: Rotavirus vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rotavirus diarrhea
Number of subjects: 0
Study: 23880148

Group type: EXPERIMENTAL
Intervention: Home-based cardiac rehabilitation program with education and practical training along with home visits by a community health nurse
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine cardiac rehabilitation program in the rehabilitation center (Control)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Home-based cardiac rehabilitation program
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine cardiac rehabilitation program (Control)
Number of subjects: 80
Study: 20210495

Group type: EXPERIMENTAL
Intervention: Sequential touching procedure for object categorization
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Individual analyses of categorization
Number of subjects: 80

Group type: COMPARATOR
Intervention: Group analyses of categorization
Number of subjects: 80
Study: 18438560

Group type: EXPERIMENTAL
Intervention: Flowable composite resin (Filtek Flow) applied on top of adhesive systems
Number of subjects: 0

Group type: COMPARATOR
Intervention: No flowable composite resin applied
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond with flowable composite
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adhesive systems tested: Scotchbond Multipurpose, Single Bond Adper Prompt, Clearfil SE Bond
Number of subjects: 0
Study: 18603890

Group type: EXPERIMENTAL
Intervention: Risperidone 4‐6 mg per day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haloperidol 10‐20 mg per day
Number of subjects: 0
Study: 12580867

Group type: EXPERIMENTAL
Intervention: Stroke patients (developed post-stroke depression)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stroke patients (not developed post-stroke depression)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects (normal subjects)
Number of subjects: 0
Study: 10381297

Group type: EXPERIMENTAL
Intervention: High-dose garlic powder dragees
Number of subjects: 152
Study: 8709585

Group type: EXPERIMENTAL
Intervention: Investigator-observed flushing after alcohol challenge (0.75 ml/kg alcohol)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Self-report of facial flushing
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 50
Study: 2058997

Group type: EXPERIMENTAL
Intervention: Low fat diet and intensive physical exercise (n = 18)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (n = 27)
Number of subjects: 45
Study: 6359913

Group type: EXPERIMENTAL
Intervention: Combination ampicillin, amikacin, and clindamycin (Group I)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combination doxycycline and penicillin (Group II)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Carbenicillin (Group III)
Number of subjects: 100
Study: 3892220

Group type: EXPERIMENTAL
Intervention: Immunosuppression plus plasma exchange
Number of subjects: 17

Group type: COMPARATOR
Intervention: Immunosuppression alone
Number of subjects: 17
Study: 30213005

Group type: COMPARATOR
Intervention: Center-based exercise training (ROT group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telemonitored home-based exercise training (ITG group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (ROT and ITG)
Number of subjects: 0
Study: 27471201

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 726

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 726
Study: 24625833

Group type: EXPERIMENTAL
Intervention: Reamer-Irrigator-Aspirator (RIA)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Iliac Crest Bone Graft (ICBG)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Posterior ICBG
Number of subjects: 133

Group type: COMPARATOR
Intervention: Anterior ICBG
Number of subjects: 133
Study: 22782050

Group type: EXPERIMENTAL
Intervention: High-fluoride dentifrice with tricalcium phosphate (5,000 ppm fluoride)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High-fluoride dentifrice without tricalcium phosphate (5,000 ppm fluoride)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Fluoride-free dentifrice
Number of subjects: 30
Study: 20834083

Group type: EXPERIMENTAL
Intervention: Artesunate plus cotrimoxazole
Number of subjects: 81

Group type: COMPARATOR
Intervention: Artesunate plus chloroquine
Number of subjects: 81
Study: 18070238

Group type: EXPERIMENTAL
Intervention: Motivational enhancement therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Social behaviour and network therapy
Number of subjects: 0
Study: 15695996

Group type: EXPERIMENTAL
Intervention: Vitamin C (1000 mg) and Vitamin E (400 IU) supplementation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 12544986

Group type: EXPERIMENTAL
Intervention: Drotrecogin alfa (activated) 24 microg/kg/hr for 96 hours
Number of subjects: 1690

Group type: EXPERIMENTAL
Intervention: Drotrecogin alfa (activated)
Number of subjects: 1690

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1690
Study: 10824881

Group type: EXPERIMENTAL
Intervention: Sitzmark capsule administration
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Plasma concentration of acetaminophen at 45 min after oral administration
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: CV(R‐R) measurement
Number of subjects: 21
Study: 8637787

Group type: EXPERIMENTAL
Intervention: 3-week benzathine penicillin G (BPG) program
Number of subjects: 249

Group type: COMPARATOR
Intervention: 4-week benzathine penicillin G (BPG) program
Number of subjects: 249
Study: 1386223

Group type: EXPERIMENTAL
Intervention: Enoximone 1.0 mg kg‐1 administered approximately 10 min before weaning from CPB
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no enoximone)
Number of subjects: 80
Study: 6366823

Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pentobarbitone (100 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31901759

Group type: EXPERIMENTAL
Intervention: Digital CBT-I intervention (6 weeks)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Control group receiving puzzles (6 weeks)
Number of subjects: 199
Study: 30850442

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10
Number of subjects: 609

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 609
Study: 27909894

Group type: EXPERIMENTAL
Intervention: aPDT + SRP
Number of subjects: 45

Group type: COMPARATOR
Intervention: MC + SRP
Number of subjects: 45

Group type: COMPARATOR
Intervention: SRP-alone
Number of subjects: 45
Study: 26162573

Group type: EXPERIMENTAL
Intervention: Topical vapocoolant spray
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 23538455

Group type: EXPERIMENTAL
Intervention: Treadmill training (two 30-minute sessions per week for seven weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Over ground gait training (two 30-minute sessions per week for seven weeks)
Number of subjects: 0
Study: 21570534

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily
Number of subjects: 4731

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4731
Study: 19670088

Group type: COMPARATOR
Intervention: Radiotherapy alone (3 fractions in 8 days)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Radiotherapy followed by hyperthermia (aimed for 43°C for 60 min)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Radiation dose of 24 Gy
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Radiation dose of 27 Gy
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Hyperthermia
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Tumor size
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Radiation dose
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Overall survival rate
Number of subjects: 70
Study: 16945896

Group type: EXPERIMENTAL
Intervention: True artificial interferences
Number of subjects: 0

Group type: COMPARATOR
Intervention: Type of intervention not specified
Number of subjects: 0
Study: 15645008

Group type: EXPERIMENTAL
Intervention: Alefacept (intramuscular or intravenous administration)
Number of subjects: 1060

Group type: EXPERIMENTAL
Intervention: Alefacept (second course of therapy)
Number of subjects: 1060

Group type: EXPERIMENTAL
Intervention: Alefacept
Number of subjects: 1060
Study: 11887654

Group type: EXPERIMENTAL
Intervention: Functionally loaded implants (group 1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unloaded one-stage control implants (group 2)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unloaded submerged technique control implants (group 3)
Number of subjects: 20
Study: 9773720

Group type: EXPERIMENTAL
Intervention: Low-starch meals (43% carbohydrate, 22% protein, 34% fat)
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-starch meals (55% carbohydrate, 15% protein, 30% fat)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Typical American meals (40% carbohydrate, 20% protein, 40% fat)
Number of subjects: 0

Group type: COMPARATOR
Intervention: All three test diets
Number of subjects: 0
Study: 7906578

Group type: EXPERIMENTAL
Intervention: 4 mg dimethindene
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 8 mg dimethindene
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3276336

Group type: EXPERIMENTAL
Intervention: Nystatin (1 ml, 100,000 units/ml) administered every 8 hours until 1 week after extubation
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no nystatin)
Number of subjects: 67
Study: 30084706

Group type: EXPERIMENTAL
Intervention: AOT (Action Observation Training)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control training (watching landscapes videos and execution)
Number of subjects: 41
Study: 28807041

Group type: EXPERIMENTAL
Intervention: Electronic Activity Monitor (EAM), Jawbone UP24 for 12 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pedometer for 12 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Focus group feedback from participants
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Overall study reception
Number of subjects: 40
Study: 25547219

Group type: EXPERIMENTAL
Intervention: YM155 plus docetaxel
Number of subjects: 101

Group type: COMPARATOR
Intervention: Docetaxel alone
Number of subjects: 101
Study: 23757437

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 375

Group type: COMPARATOR
Intervention: Diabetes support and education (DSE)
Number of subjects: 375
Study: 22232848

Group type: COMPARATOR
Intervention: Tablets containing soy isoflavones 60 mg (genistin 30 mg + daidzin 30 mg) + calcium and vitamin D3
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tablets containing soy isoflavones 60 mg (genistin 30 mg + daidzin 30 mg) + calcium and vitamin D3 + 500 million vital spores of Lactobacillus sporogenes
Number of subjects: 12
Study: 19523772

Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (TD)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 16237394

Group type: EXPERIMENTAL
Intervention: Olanzapine (5 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15884482

Group type: EXPERIMENTAL
Intervention: Listening to preferred music while out of restraining devices
Number of subjects: 30

Group type: COMPARATOR
Intervention: No music while out of restraining devices
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Listening to preferred music while in restraining devices
Number of subjects: 30
Study: 11076169

Group type: EXPERIMENTAL
Intervention: Evidence-based medicine (EBM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consumer Reports study
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Empirically Supported Treatments
Number of subjects: 0
Study: 9348569

Group type: EXPERIMENTAL
Intervention: UFT plus leucovorin
Number of subjects: 312

Group type: COMPARATOR
Intervention: 5-FU plus leucovorin
Number of subjects: 312
Study: 8328783

Group type: EXPERIMENTAL
Intervention: novobiocin plus rifampin
Number of subjects: 94

Group type: COMPARATOR
Intervention: T/S plus rifampin
Number of subjects: 94
Study: 3828866

Group type: EXPERIMENTAL
Intervention: Comprehensive professional development workshop
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 29706691

Group type: EXPERIMENTAL
Intervention: Self-mobilization group (SMG) performed upper thoracic self-mobilization using a Kaltenborn wedge
Number of subjects: 27

Group type: COMPARATOR
Intervention: Self-stretching group (SSG) performed self-stretching exercises
Number of subjects: 27
Study: 27161493

Group type: EXPERIMENTAL
Intervention: Combined aerobic and strength training program (24 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study: 24903556

Group type: EXPERIMENTAL
Intervention: Prophylactic bicyclol (75 mg, oral, daily)
Number of subjects: 306

Group type: COMPARATOR
Intervention: Control (chemotherapy alone)
Number of subjects: 306
Study: 22793958

Group type: EXPERIMENTAL
Intervention: Eyelet wiring
Number of subjects: 0

Group type: COMPARATOR
Intervention: Direct interdental wiring
Number of subjects: 0
Study: 20685497

Group type: EXPERIMENTAL
Intervention: Basal-bolus therapy (BBT) with insulin glargine once daily plus mealtime insulin lispro TID
Number of subjects: 2091

Group type: COMPARATOR
Intervention: LM75/25 (75% insulin lispro protamine suspension and 25% insulin lispro injection) BID
Number of subjects: 2091

Group type: COMPARATOR
Intervention: LM50/50 (50% insulin lispro protamine suspension and 50% insulin lispro injection) TID
Number of subjects: 2091
Study: 18024231

Group type: EXPERIMENTAL
Intervention: Exercise group (supervised aerobic exercise for 4 months, 16 kcal kg(‐1) week(‐1), 60‐80% VO(2) max)
Number of subjects: 170
Study: 17033111

Group type: EXPERIMENTAL
Intervention: Amoxicillin with clarithromycin and proton pump inhibitor (PPI)
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Tetracycline, tinidazole, bismuth and PPI
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Amoxicillin with clarithromycin and PPI supplemented with Lacidofil
Number of subjects: 641

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 641
Study: 12812378

Group type: EXPERIMENTAL
Intervention: Venoruton (HR)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 10608746

Group type: EXPERIMENTAL
Intervention: pleconaril 200 mg twice daily (initial dose of 400 mg)
Number of subjects: 33

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 33
Study: 8859234

Group type: EXPERIMENTAL
Intervention: 4-mg intravenous ondansetron
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 32
Study: 7959523

Group type: EXPERIMENTAL
Intervention: Paroxetine (1x20 mg/day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Doxepin (2x50 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 3298420

Group type: EXPERIMENTAL
Intervention: Moclobemide (selective MAO-A-inhibitor)
Number of subjects: 23
Study: 30153034

Group type: EXPERIMENTAL
Intervention: Highlighted utensils
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-highlighted utensils
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dark setting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal vision setting
Number of subjects: 0